Ziopharm Oncology reported $88.28M in Equity Capital and Reserves for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Equity Capital And Reserves Change
Amgen AMGN:US $ 8247M 1087M
Arena Pharmaceuticals ARNA:US $ 971.08M 114.91M
AstraZeneca AZN:LN 15676M 1246M
Baxter International BAX:US $ 8494M 42M
Biogen BIIB:US $ 10751.9M 69.7M
Bristol Myers Squibb BMY:US $ 36808M 797M
Corcept Therapeutics CORT:US $ 522.67M 11.87M
Curis CRIS:US $ 112.47M 9.44M
Eleven Biotherapeutics EBIO:US $ 49.35M 40.08M
Gilead Sciences GILD:US $ 19710M 758M
GlaxoSmithKline GSK:LN 15377M 512M
Immunogen IMGN:US $ 68.46M 25.66M
Intercept Pharmaceuticals ICPT:US $ -203.2M 3.2M
Intrexon XON:US $ 159.2M 15.6M
IONIS PHARMACEUT IONS:US $ 582.67M 97.89M
Karyopharm Therapeutics KPTI:US $ -83132000 43.49M
Novartis NOVN:VX SF 54042M 3519M
Ptc Therapeutics PTCT:US $ 196.58M 96M
Regeneron Pharmaceuticals REGN:US $ 15127.3M 3150.3M
Sangamo Biosciences SGMO:US $ 445.46M 24.9M
Tg Therapeutics TGTX:US $ 383.13M 62.16M
Verastem VSTM:US $ 88.2M 14.4M
YTE INCY:US $ 2935.86M 208.02M
Ziopharm Oncology ZIOP:US $ 88.28M 17.36M